WellDyne Receives PBMI Excellence Award

Known for its innovative clinical care model, WellDyne has been recognized with a PBMI Excellence Award for Care Management Strategies, acknowledging the highly effective approach that ensures care decisions are more precise and appropriate. David Skomo, SVP, Chief Pharmacy Operations Officer, accepted the award on behalf of WellDyne at September’s PBMI National Conference in Orlando.

“Through better monitoring, multiple touchpoints and real-time adjustments, we risk-stratify patients, identify those who need additional support for best management of their conditions and accommodate others who may want to check in with us less,” explains David. “Our clinical care model allows us to apply care where it’s needed most.”

Specialty pharmacies have traditionally followed a one-size-fits-all approach, with patients receiving the same interactions on the same schedule. To achieve a holistic picture of each patient’s health, WellDyne combines information from connected devices, providers, patient reported outcomes and surveys to support better treatment decisions.

“Technology is speeding forward with new capabilities that influence better health outcomes and savings,” says Jeff Park, WellDyne Chairman and CEO. “At WellDyne, we invest in leading-edge tools and technologies to ensure patients receive the benefit of healthcare innovations.”

To learn more about the WellDyne clinical care model, view our August 2021 webinar, Better Together: Patient Engagement Model of the Future.

The Pharmacy Benefit Management Institute (PBMI) is the nation’s leading provider of research and education that informs, advises and influences the industry on drug cost management. PBMI Excellence Awards have been presented annually since 2016, with nominees evaluated on their pharmacy benefit management programs or product success in improving outcomes or processes within drug cost management, quality improvement or care management.